To Be Determined To Be Determined

A Lindsay Bishop serves as the Program Point of Contact for the Centers for Disease Control and Prevention, playing a critical role in aligning acquisition strategies with the agency’s public health mission. Responsible for bridging scientific and operational needs with procurement processes, Bishop facilitates the acquisition of technical services and specialized equipment essential to disease surveillance, laboratory diagnostics, and emergency response capabilities. While not a contracting officer, they provide essential programmatic input during the requirements definition, source selection, and contract administration phases, ensuring that procurements directly support CDC’s strategic priorities in infectious disease control and public health infrastructure enhancement. Bishop collaborates closely with a diverse network of federal contractors, including research institutions, diagnostic technology firms, and data analytics vendors, to deliver mission-critical solutions. Their working relationships emphasize long-term partnerships with entities capable of supporting rapid-scale deployment of laboratory systems, real-time epidemiological tools, and biosafety-compliant equipment. These collaborations often involve complex, multi-year task orders requiring high levels of technical interoperability and regulatory compliance. While specific set-aside preferences are not publicly documented, Bishop’s programmatic focus aligns with CDC’s broader commitment to socioeconomic contracting, routinely engaging 8(a), HUBZone, and SDVOSB-certified firms that provide niche services in public health informatics, environmental monitoring, and field deployment logistics. Their procurement patterns reflect a deliberate effort to foster innovation through small business participation while maintaining compliance with federal socioeconomic goals. Bishop’s primary industry focus centers on NAICS categories related to scientific research and development, medical laboratory services, and health information technology. They routinely procure advanced diagnostic instruments, biosurveillance software, data integration platforms, and field-ready diagnostic kits, demonstrating deep expertise in the technical domains of molecular diagnostics, outbreak response systems, and public health data interoperability. Their work ensures that CDC’s procurement activities remain responsive to evolving public health threats and scientific advancements.